Macugen: First anti-VEGF Eye Injection….so, Where’s Waldo?

Like the image game "Waldo," Macugen® seems to be lost in a sea of literature about other anti-VEGF intraocular injections.  Macugen was; however, the first intraocular injection for the treatment of wet macular degeneration.  It became FDA approved for the treatment of wet ARMD in 2004.  Where is it now? The First anti-VEGF Intraocular Injection. Quite simply, this was a significant change … [Read more...]

Diabetic Retinopathy Vs. Macular Degeneration (Part 2 of 2)

Good Morning!  This is part 2 of 2.  Part 1 was posted yesterday.  Read Part 1. 6.  Treatment with Avastin® or other anti-VEGF inhibitors Technically, both diseases may be treated with anti-VEGF inhibitors. Presently, I sometimes treat the neovascular component of diabetic retinopathy with Avastin® if pan-retinal laser photocoagulation (standard treatment) fails.  More often, using … [Read more...]

Diabetics Get Cataracts

Cataracts are like grey hair..............everyone gets cataracts, some at an early age and some at a later age.  Period. Cataracts are generally not inherited (okay, there are some inherited or congenital cataracts seen in kids).  There are many factors that may influence the development of a cataract; ultraviolet rays from the sun, trauma, previous eye surgery and .... diabetes.  While … [Read more...]

Cases of ARMD to Double

In this month's (April,  2009) edition of Archives of Ophthalmology, a study reports the prevalence of patients afflicted with macular degeneration is expected to almost double by the year 2050.  In other words, the number of patients suffering the disease at a given time is expected to near double in the next 40 years. All forms of macular degeneration are expected to increase over the next … [Read more...]

Web Strategy by Medical Marketing Enterprises, LLC